Advanced Wound Care Device for Diagnostic Imaging

MolecuLight i:X® & DX
FDA CLEARED
The leading point-of-care wound imaging devices for the detection of the presence and location of elevated bacterial loads and for accurate digital wound measurement.
Learn how they work:

MolecuLight was recently featured in:

MolecuLight i:X & DX may help at every stage of wound care

MolecuLight i:X device, front
Play button
Assessment
Cleaning
Debridement
Sampling
Documentation
Treatment Selection
Antibiotic Stewardship
Patient Engagement

Assessment

Visualize fluorescent bacteria and measure wound surface area in real-time to understand the status of the wound more fully.1,3

Cleaning

Allows clinicians to focus cleaning in areas where fluorescent bacteria are located and optimize wound bed preparation.10

Debridement

Guides more efficient and targeted debridement.2,6,7

Sampling

Guides where to sample; 54% more accurate swabbing compared to the Levine technique.3

Assessment

Visualize fluorescent bacteria and measure wound surface area in real-time to understand the status of the wound more fully.1,3

Cleaning

Allows clinicians to focus cleaning in areas where fluorescent bacteria are located and optimize wound bed preparation.10

Debridement

Guides more efficient and targeted debridement.2,6,7

Sampling

Guides where to sample; 54% more accurate swabbing compared to the Levine technique.3

Documentation>

Provides objective visual documentation of the presence of fluorescent bacteria and the surface area of the wound.2,9

Treatment Selection

Comparing fluorescent bacteria and wound surface area at each visit may provide real-time objective feedback on impact of treatment plan.1,2,4

Antibiotic Stewardship

Supports more responsible antibiotic decision making and selection.6,8,9

Patient Engagement

Patients easily see and understand why a clinician is taking certain action to clean, debride, and treat a wound in a specific way.4,5

Watch MolecuLight i:X in action

The MolecuLight i:X Wound Imaging Device allows clinicians to quickly, safely, and easily visualize bacteria2 and measure wounds7 at the point of care, so they have maximum insights for accurate treatment selection and accelerated healing.

New peer-reviewed publications featuring MolecuLight appeared in:

CASE STUDY

Real-Time Detection of Asymptomatic Bioburden in Wounds

Use of the MolecuLight i:X to image for bacterial fluorescence, in conjunction with clinical signs & symptoms, adds an additional bacterial-specific piece of information that can be captured and considered in real-time.

See Full Case Study

Testimonials

"The MolecuLight i:X has transformed my clinical decision making. MolecuLight i:X helps reveal the unexpected and eliminates guess work."

Rosemary Hill, BSN CWOCN CETN(C) // Vancouver Coastal Health, North Vancouver, Canada

"The MolecuLight i:X completely changed my decision making and resulted in not only time and cost savings but also improved patient outcomes.”

Lt Col Steven Jeffery // The Royal Centre for Defence Medicine, Birmingham, UK

"The MolecuLight i:X gives clinicians the ability to visualize and therefore target treatment towards clinically undetectable critical colonization. This user friendly point-of-care device is an exciting addition to our wound care protocol."

David Russell, MD // Leeds Teaching Hospitals, Leeds, UK